1% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1466

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for 1% Lidocaine Hci (NDC 51662-1466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (51662-1466-1 50 mL VIAL SERIALIZED LABELING)

This is a description of a pharmaceutical product: Lidocaine H(l i Injection, USP with 10mg/mL strength of 500 mg/50 mL. The batch number is 05-137-DK, and it is the subject of the manufacturer's package insert. It is distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. It is meant for prescription use only.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTTION 1)

This is a description of a medication called Lidocaine HCl Injection, USP, in a 50 ml container with a concentration of 500mg/50ml. It is prescribed for infiltration and nerve block and is not recommended for subarachnoid or caudal use. The medication contains lidocaine hydrochloride, sodium chloride, and methylparaben as a preservative. The pH level adjustment may contain HCl and/or NaOH. Usual dosage and storage instructions are provided. The medication is distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 2)

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 3)

This is a prescription drug with the NDC code 0409-4276-17. The drug is a multiple-dose solution for infiltration and nerve block. It should not be used for lumbar and caudal procedures. The solution contains lidocaine hydrochloride and a preservative. The dosage and storage information can be found in the insert. The drug is produced by Hospira, Inc.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 4)

This is a description of a Lidocaine HCI injection, which contains 500mg/50mL (10mg/mL) solution, prescribed for infiltration and nerve block. It is sterile, non-pyrogenic, and each mL contains lidocaine hydrochloride, anhydrous 10mg, sodium chloride 7mg, and methylparaben 1mg. It is available only on prescription and must be stored between 20 to 25°C (68 to 77°F). It comes in a prescription packaging box, containing 1 NDC 0409-4276-17. Further information is available in the insert provided within the box.*

FDA Label Image

Principal Display Panel (51662-1466 50 mL VIAL LABEL OPTION 5)

FDA Label Image

51662 1466 2 Pouch Labeling

This is a 50mL vial of 1% Lidocaine HCI Injection, USP containing 500mg/50mL (10mg/mL) solution. It is used for infiltration and nerve block, but not for epidural or caudal use. It is sterile, non-pyrogenic, and contains preservatives. The usual dosage is provided in the insert. The product should be stored at 20 to 25°C (68 to 77°F) and aseptic technique should be used for administration. The plastic vial needs to be cleansed with an antiseptic and should only be used if clear and the seal is intact and undamaged. The manufacturer's package insert should be consulted. This product is only available by prescription and is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275.*

FDA Label Image

51662 1466 3 Box Labeling

1% Lidocaine HCI Injection is a sterile and non-pyrogenic solution with 500mg/50mL (10mg/mL) of Lidocaine HCI in each vial. It is intended for infiltration and nerve block and not for epidural or caudal use. The solution contains a preservative and should be stored at temperatures between 20°C to 25°C. Before use, the stopper should be cleansed with an antiseptic and the solution must be clear, intact and undamaged. The usual dose of the solution should be consulted from the insert provided by the manufacturer. The product is available in a box of 25 vials each having a size of 50mL. The manufacturer's name is HF Acquisition Co., LLC, located in Mukilteo, WA, and the product's original National Drug Code (NDC) is 0409-4276-02.*

FDA Label Image

51662 1466 3 Serialized Labeling

FDA Label Image

Alt 2 Vial Label

FDA Label Image

Alt 3 Vial Label

This is a label for Lidocaine HC Injection. The notes provide instructions on the preferred font size and color for the commodity number and barcode, as well as guidelines for the use of solid PMS black for ablation marking. No further information is available.*

FDA Label Image

Alt Vial Label

This is a label for a 50mL injection of docaine USP for vertical ablation. The label has 2 lines of variable information in 6pt font for ablation marking. The font size for the commodity number is preferred to be 6 point B medium with a minimum font size of 4.5 point, and it needs to be black on white background. There are also instructions for the barcode, stating that human readable information below the barcode is not required except for the Canadian market, and a quiet zone is not required.*

FDA Label Image

Description (Description)

This appears to be a table showing the concentration of lidocaine HC (hydrochloride) and sodium chloride based on different milligram per milliliter measurements. It is unclear what the purpose of this concentration is for without further context.*

FDA Label Image

D And A 1 (Dosage And Administration 1)

This is a description of different concentrations and sizes of single-dose containers for a medication. The product comes in vials and ampuls. The concentrations available are 1%, 1.5%, and 2%. The sizes of the vials and ampuls are 30 mL, 20 mL, and 10 mL respectively.*

FDA Label Image

D And A 2 (Dosage And Administration 2)

This is a table displaying the recommended concentration, volume, and total dose of Lidocaine Hydrochloride Injection, USP based on various medical procedures such as infiltration, intravenous regional, and neural blocks. It also includes suggestions for epidural and caudal blocks for analgesia and anesthesia purposes.*

FDA Label Image

How Supplied 1 (How Supplied 1)

Unit of Sale Concentration includes the National Drug Code numbers, Quantity and concentration of various products. These include Tray of 25 Glass Teartop Vials with concentration 5%, 1%, and 1%, a Case of 800 Glass Ampuls with concentration 1% and 50 mg/5 mL , Carton of 25 Glass Ampuls with concentration 1.5% & 2%.*

FDA Label Image

How Supplied 2 (How Supplied 2)

This text provides information on the unit of sale and concentration for various NDC products, including bundle and tray configurations. The products listed have varying concentrations ranging from 5mg/mL to 20mg/mL and come in different packaging sizes such as clamcells and plastic fliptop vials.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

This text provides examples of various classes of drugs, including nitrates/nitrites, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs like acetaminophen, metoclopramide, quinine, sulfasalazine. It can be useful for educational or reference purposes.*

FDA Label Image

Superseeded Vial Label

This is a product information sheet for Lidocaine HCl Injection, USP, with a concentration of 500 mg/50 mL (10 mg/ml). The sheet includes a product code (Ruony NDCO0409-4276:17) and mentions that the document is named QRL-4676v3.indd I s 282. The rest of the text appears to be illegible due to errors.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label

This file is a barcode specification sheet for a lidocaine HCI injection used in the United States. The barcode uses the GS1 Databar Limited symbology and contains the readable information "(01)00304084275175". The components of the barcode are not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.